Value Investing through Gurus model portfolios. | Equity School | - B - Bafna Pharmaceuticals Ltd

You are here: Home

Balance Sheet of Bafna Pharmaceuticals Ltd

Balance Sheet of Bafna Pharmaceuticals Ltd

	Mar2008	Mar2007	Mar2006	Mar2005	Mar2004
SOURCES OF FUNDS:
Share Capital	9.58	3.87	3.87	2.58	0.46
Reserves & Surplus	2.27	2.50	1.54	1.68	2.61
Total Shareholders Funds	11.85	6.37	5.41	4.26	3.07
Secured Loans	23.20	15.85	11.46	6.72	1.84
Unsecured Loans	1.60	1.26	0.00	0.06	0.06
Total Debt	24.80	17.11	11.46	6.78	1.90
Total Liabilities	36.65	23.48	16.87	11.04	4.97
APPLICATION OF FUNDS:
Gross Block	4.42	4.23	4.96	3.26	3.01
Less: Accum. Depreciation	2.08	1.74	1.37	1.10	0.93
Net Block	2.34	2.49	3.59	2.16	2.08
Capital Work in Progress	29.76	23.02	4.45	1.47	0.00
Investments	0.00	0.00	0.00	0.00	0.00
Inventories	5.37	6.56	4.97	5.85	2.72
Sundry Debtors	10.09	18.41	4.96	4.27	3.89
Cash and Bank Balance	1.19	1.77	1.08	1.17	0.50
Loans and Advances	2.02	1.71	2.35	1.92	0.39
Current Liabilities	14.19	30.40	4.42	5.30	4.38
Provisions	0.19	0.13	0.17	0.51	0.23
Net Current Assets	4.29	-2.08	8.77	7.40	2.89
Miscellaneous Expenses not w/o	0.26	0.05	0.06	0.01	0.00
Total Assets	36.65	23.48	16.87	11.04	4.97
Contingent Liabilities	4.86	4.58	1.24	2.21	0.78

High Dividend, High Value, Fast Growth - Stock Research Based on Strategies of the Pros, including Warren Buffett, Peter Lynch and Ben Graham